Ya-Ling Wei

Elevated BCRP/ABCG2 Expression Confers Acquired Resistance to Gefitinib in Wild-Type EGFR-Expressing Cells

Yun‐Ju Chen, Wei‐Chien Huang, Ya-Ling Wei et al. · PLoS ONE · 2011 · 78 citations · Full text

Medicine, Oncology, Pharmacology +16

Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors

Yun‐Ju Chen, Ming‐Hsin Yeh, Meng-Chieh Yu et al. · Breast Cancer Research · 2013 · 73 citations · Full text

Medicine, Oncology, Pharmacology +13

A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition

Jian’an Bai, Na He, Xiumei Hua et al. · Oncotarget · 2016 · 41 citations · Full text

Life Sciences, Molecular Medicine, Pathobiology +15

Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells

Te‐Chun Hsia, Chih‐Yen Tu, Yun‐Ju Chen et al. · Molecular Pharmacology · 2013 · 37 citations

Medicine, Oncology, Pharmacology +16

Cigarette smoke-induced LKB1/AMPK pathway deficiency reduces EGFR TKI sensitivity in NSCLC

Fang‐Ju Cheng, Chia‐Hung Chen, Wen‐Chen Tsai et al. · Oncogene · 2020 · 37 citations · Full text

Medicine, Oncology, Pharmacology +17